"HLA-A3 Antigen"[nm] - Search Results

Year	Number of Results
1981	1
1982	5
1983	6
1984	15
1985	14
1986	7
1987	8
1988	10
1989	9
1990	8
1991	13
1992	9
1993	11
1994	14
1995	7
1996	13
1997	11
1998	12
1999	9
2000	8
2001	11
2002	8
2003	9
2004	27
2005	12
2006	12
2007	10
2008	9
2009	10
2010	12
2011	10
2012	8
2013	6
2014	8
2015	9
2016	7
2017	4
2018	5
2019	7
2020	4
2021	3
2022	3
2023	2
2024	0

1

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.

Naranbhai V, Viard M, Dean M, Groha S, Braun DA, Labaki C, Shukla SA, Yuki Y, Shah P, Chin K, Wind-Rotolo M, Mu XJ, Robbins PB, Gusev A, Choueiri TK, Gulley JL, Carrington M. Naranbhai V, et al. Lancet Oncol. 2022 Jan;23(1):172-184. doi: 10.1016/S1470-2045(21)00582-9. Epub 2021 Dec 9. Lancet Oncol. 2022. PMID: 34895481 Free PMC article.

2

Monoclonal antibody to HLA-A3.

Berger AE, Davis JE, Cresswell P. Berger AE, et al. Hybridoma. 1982;1(2):87-90. doi: 10.1089/hyb.1.1982.1.87. Hybridoma. 1982. PMID: 6208124

3

[Uveitis].

Correia J, Barbosa P, Paiva P, Ferreira A, Vasconcelos C, Leão B, Marques M, Torres P, Branco H, Da Silva BM. Correia J, et al. Acta Med Port. 1998 Oct;11(10):877-81. Acta Med Port. 1998. PMID: 10021782 Free article. Portuguese.

4

Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.

Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Vonderheide RH, et al. Clin Cancer Res. 2001 Nov;7(11):3343-8. Clin Cancer Res. 2001. PMID: 11705846

5

Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.

Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E. Kawashima I, et al. Cancer Res. 1999 Jan 15;59(2):431-5. Cancer Res. 1999. PMID: 9927058

6

HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.

Posthuma EF, Falkenburg JH, Apperley JF, Gratwohl A, Roosnek E, Hertenstein B, Schipper RF, Schreuder GM, D'Amaro J, Oudshoorn M, van Biezen JH, Hermans J, Willemze R, Niederwieser D. Posthuma EF, et al. Blood. 1999 Jun 1;93(11):3863-5. Blood. 1999. PMID: 10339494 Free article.

7

Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.

Lim WC, Khan AM. Lim WC, et al. BMC Genomics. 2018 Jan 19;19(Suppl 1):42. doi: 10.1186/s12864-017-4328-8. BMC Genomics. 2018. PMID: 29363421 Free PMC article.

8

The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.

Olynyk JK, Grainger R, Currie H, Ramm LE, Ramm GA. Olynyk JK, et al. Sci Rep. 2023 May 13;13(1):7775. doi: 10.1038/s41598-023-35028-4. Sci Rep. 2023. PMID: 37179448 Free PMC article.

9

Chimeric HLA antibody receptor T cells to target HLA-specific B cells in solid organ transplantation.

Gille I, Hagedoorn RS, van der Meer-Prins EMW, Heemskerk MHM, Heidt S. Gille I, et al. HLA. 2023 Oct;102(4):436-448. doi: 10.1111/tan.15146. Epub 2023 Jun 27. HLA. 2023. PMID: 37370222

10

HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.

DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE. DiBrino M, et al. J Immunol. 1993 Dec 1;151(11):5930-5. J Immunol. 1993. PMID: 7504010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

359 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Results by year